Technology | Patient Monitors | August 14, 2015

Nonin Medical Launches Apple iOS-compatible Wireless Finger Pulse Oximeter

Bluetooth Smart connectivity allows remote monitoring of SpO2  readings to help manage COPD

Nonin Medical, NoninConnect Model 3230, Bluetooth Smart, wireless finger pulse oximeter, iOS-compatible, Apple

Image courtesy of Nonin Medical


August 14, 2015 — Nonin Medical Inc. announced it has launched the NoninConnect Model 3230 Bluetooth Smart wireless finger pulse oximeter and Apple iOS mobile app to clinicians and patients outside of the United States.

The NoninConnect wireless finger pulse oximeter combines Nonin's PureSAT pulse oximetry signal processing technology with state-of-the-art Bluetooth Smart (low energy) wireless technology in an easy-to-use connected finger pulse oximeter that measures arterial blood oxygen saturation and pulse rate. The device helps clinicians and patients proactively identify issues for early intervention, helping to avoid re-hospitalization.

With NoninConnect, clinicians can remotely (up to 10 meters) view their patients' SpO2 readings in real time. Patients can easily monitor and share their SpO2 data by downloading the NoninConnect iOS mobile app on their compatible Apple device. Compatible devices include: iPhone 4S and newer, iPad 3 and newer, all iPad Air and iPad Minis, and the iPod Touch 5th edition and newer (with Apple iOS 8.1 or newer installed).

NoninConnect Model 3230 advantages include:

  • An easy-to-read, large, clear user-facing display;
  • A long battery life – allows for up to 2,200 spot checks on two AAA batteries;
  • Simplified wireless pairing to Bluetooth Smart Ready Apple iOS devices;
  • Nonin CorrectCheck Finger Placement Technology, which provides feedback via a digital display if user's finger is not placed correctly in the device; and
  • Nonin SmartPoint Capture and Send Technology, which automatically determines when a high-quality measurement is ready to be wirelessly transmitted.

For more information: www.nonin.com


Related Content

Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Feature | Cardiac Diagnostics | By Adam Saltman, MD, PhD

Before opining on the future of cardiac health, I think it’s important to define what “cardiac health” actually is. If ...

Home May 04, 2022
Home
News | Cardiac Diagnostics

January 31, 2022 — Scientists have developed an artificial intelligence (AI) system that can analyze eye scans taken ...

Home January 31, 2022
Home
News | Cardiac Diagnostics

November 10, 2021 — Abbott released new global market research from its Beyond Intervention initiative, the company’s ...

Home November 10, 2021
Home
Feature | Cardiac Diagnostics | By Dave Fornell, DAIC Editor

October 29, 2021 — A new guideline for the evaluation and diagnosis of chest pain was released this week that provides ...

Home October 29, 2021
Home
Subscribe Now